-
Research Integrity and Scholarly Excellence Lecture Series features health policy and medical decision-making expert | VTx
The Division of Scholarly Integrity and Research Compliance in the Office for Research and Innovation is hosting its fall lecture in the Research Integrity and Scholarly Excellence (RISE) Lecture Series: Reproducibility and Replicability in Science on Sept. 16 at noon. This year marks the second year of the RISE Lecture Series. Invited guest speaker Harvey V. Fineberg, president of the Gordon and Betty Moore Foundation, will discuss the importance of reproducibility and replicability in science. Fineberg, former president of the National Academy of Medicine, chaired the National Academies committee on this topic, which resulted in a widely referenced report … Read more
-
Pragmatic clinical trials: An update on NIA-funded real-world research to improve patient care
Marcel SALIVE, Health Scientist Administrator,Division of Geriatrics and Clinical Gerontology (DGCG). As faithful readers may remember from my blog post several years ago, pragmatic clinical trials enable researchers to identify and test interventions in real-world situations and settings, such as hospitals, clinics, or physician practices. Because they are connecting with older adults where they already live and receive care, these types of clinical trials may allow for testing in more diverse older adult populations. This is critical for ensuring research findings translate to meaningful improvements in health outcomes for older adults. NIH supports innovative pragmatic trials NIA, along … Read more
-
UK announces five new COVID-19 vaccine research projects
A number of new studies have been rolled-out to analyse the durability of vaccine responses, low responses linked with health conditions and the effect of booster shots. The studies will research a wide range of people including individuals with a weakened immune system, people who are obese, healthcare workers and people with a weak vaccine response. WHY IT MATTERS These studies aim to determine how long immunity from the vaccine lasts, identify groups of people at risk from low vaccine responses and determine if and when vaccine boosters are required for these groups, as well as the wider population. The … Read more
